2026 Orthopedic Device Industry M&A Roundup (Updated 6/18)

Merger and acquisition (M&A) transactions remain prevalent in the orthopedic device manufacturing industry in many forms—large organizations purchasing smaller, innovative companies and/or businesses, mergers of equals, private equity deals, and orthopedic device contract manufacturers grabbing specialty businesses to round out their offerings.

To help our readers stay up to date about the orthopedic device market’s evolution, ODT will catalog these M&A transactions throughout the year. We hope this will be a helpful resource!

EBI—Xstim

Xstim develops next-gen bone growth stimulation solutions, including a modern, wearable, non-invasive spine fusion stimulation therapy.
Date of Announcement: June 18, 2026
Value: Not disclosed
More info

Amplio Spine—FloSpine

Amplio acquired FloSpine’s KeyLift expandable interlaminar stabilization system, a non-pedicle, supplemental fixation device for use at a single level in the non-cervical spine (T1-S1).
Date of Announcement: June 18, 2026
Value: Not disclosed
More info

DePuy Synthes—MinMaxMedical

DePuy Synthes will acquire the company’s in-development Gemtrack radiofrequency (RF) miniature tracker tech for joint reconstruction procedures.
Date of Announcement: May 26, 2026
Value: Not disclosed
More info

Medtronic—SPR Therapeutics

SPR’s FDA-cleared Sprint PNS system is a short-term, 60-day therapy engineered to offer pain relief through a temporary approach that doesn’t require a permanent implant.
Date of Announcement: May 20, 2026
Value: $650 million
More info

Atreon Orthopedics—RenovoDerm

Atreon Orthopedics LLC and RenovoDerm LLC have merged, creating a company that aims to deliver synthetic biomaterials for tissue repair and remodeling. 
Date of Announcement: May 19, 2026
Value: Not disclosed
More info

Bioness—Portable Neuromodulation Stimulator (PoNS) System

Adding the PoNS system expands the company’s platform to include non-invasive neuromodulation delivered via the tongue, stimulating cranial nerve pathways to promote neuroplasticity and functional recovery.
Date of Announcement: April 9, 2026
Value: Not disclosed
More info

Oury Medical Group—Céfiméca

Céfiméca is an orthopedic implant and spinal instrument maker. The transaction represents a new major step in Oury Medical Group’s development and is consistent with the long-term industrial strategy initiated by TAG Partners upon Oury-Guyé’s purchase three years ago.
Date of announcement: April 1, 2026
Value: Not disclosed
More info

Zavation—ChoiceSpine

ChoiceSpine adds a comprehensive portfolio of spinal implant and instrumentation systems spanning cervical, thoracolumbar, and interbody applications.
Date of Announcement: February 26, 2026
Value: Not disclosed
More info

VB Spine—xvision Spine System

VB Spine is acquiring exclusive rights to the xvision Spine System from Augmedics, adding augmented reality (AR) navigation to its enhanced visualization portfolio.
Date of Announcement: February 16, 2026 (closed April 13, 2026)
Value: Not disclosed
More info

VB Spine—Robotron Surgical Technologies

VB Spine will acquire Robotron’s SpineHawk platform, adding intraoperative spinal visualization and a software roadmap to support tech-enabled spine care.
Date of Announcement: January 15, 2026
Value: Not disclosed
More info

Tecomet—Orchid Orthopedic Solutions

The companies began an agreement to merge, combining complementary capabilities to better serve customers, expand reach, and support long-term growth.
Date of Announcement: January 14, 2026 (closed May 14, 2026)
Value: Not disclosed
More info

Smith+Nephew—Integrity Orthopaedics

Integrity is the early-stage developer of Tendon Seam, a rotator cuff repair system designed to reduce re-tear rates and improve outcomes.
Date of Announcement: January 12, 2026
Value: $225 million upfront, up to an additional $225 million in performance-based payments
More info

VB Spine—Stryker

VB Spine completed the acquisition of Stryker’s spine implant manufacturing facility in Cestas, France.
Date of Announcement: January 6, 2026
Value: Not disclosed
More info

Year-by-Year

2025 Orthopedic Device Companies M&A Roundup
2024 Orthopedic Device M&A Roundup